DMC Cardiovascular Institute among first in nation to adopt newly-approved miniature Cardiac Monitor
Small, Wireless Monitor Provides Long-Term Remote Monitoring to Help Diagnose and Monitor Irregular Heartbeats
DMC Cardiovascular Institute is one of the first hospitals in the nation to implant the Medtronic Reveal LINQ Insertable Cardiac Monitor (ICM) System in a patient, the smallest implantable cardiac monitoring device available. In in less than two hours of receiving the product through customs from Switzerland, DMC implanted one of the first if not the first in USA. DMC was chosen to be one of the first centers to implant the device, based upon the advanced level of cardiac care at DMC Cardiovascular Institute.
The Reveal LINQ ICM is approximately one-third the size of a AAA battery (~1 cc), making it more than 80 percent smaller than other ICMs. While significantly smaller, the device is part of a powerful system that allows physicians to continuously and wirelessly monitor a patient’s heart for up to three years, with 20 percent more data memory than its larger predecessor, Reveal® XT.
The first device was installed Saturday, February 22, by Randy Lieberman, MD, Cardiologist and Cardiac Electrophysiologist. “The Reveal LINQ ICM is so discreet that most patients will not even know it is there and can go about their lives without interruption or discomfort from the device,” said Dr. Lieberman. “Additionally, the device has the ability to communicate wirelessly with the patient’s physician via the MyCareLink™ Patient Monitor while the patient is sleeping, allowing them to continue living their lives normally, even when travelling away from home, from nearly any location in the world.”
In addition to its continuous and wireless monitoring capabilities, the system provides remote monitoring through the Carelink® Network. Through the Carelink Network, physicians can request notifications to alert them if their patients have had cardiac events. The Reveal LINQ ICM is indicated for patients who experience symptoms such as dizziness, palpitation, syncope (fainting) and chest pain that may suggest a cardiac arrhythmia, and for patients at increased risk for cardiac arrhythmias.
Randy A. Liberman, MD
Theodore L. Schreiber, MD,
FACC, FCCP, FSCAI
Placed just beneath the skin through a small incision of less than 1 cm in the upper left side of the chest, the Reveal LINQ ICM is often nearly invisible to the naked eye once inserted. The device is placed using a minimally invasive insertion procedure, which simplifies the experience for both physicians and their patients. The Reveal LINQ ICM is MR-Conditional, allowing patients to undergo magnetic resonance imaging (MRI) if needed.
By offering the Reveal LINQ ICM to patients, DMC Cardiovascular Institute is continuing to lead the way by using the latest technology to diagnose and treat heart disease. “We’re proud to bring this state-of-the-art technology to Detroit,” Said Dr. Theodore Schreiber, President of DMC Cardiovascular Institute and the DMC Heart Hospital, opening in the summer of 2014. “The device revolutionizes the whole clinical approach to the workup and management of symptoms potentially caused by arrhythmias of the heart, and is likely to prevent many, many strokes due to atrial fibrillation. It illustrates our dedication to consistently delivering the best heart care to this region, as soon as it becomes available.”